Price, availability and affordability of medicines in Georgia

26 Jan, 2011

With the support of the Open Society Institute and the World Bank CIF wrapped up the second stage of the study exploring “Price, availability and affordability of medicines in Georgia” in December, 2010.

The study aimed at increasing awareness of civil society and improved access to medicines for the population through strengthening respective evidence. Field works during the first stage of the study were conducted in December 2009, while the second phase of inquiry in July 2010. During the second phase the research covered four Georgian regions involving 146 pharmacies.

The report   “Price, availability and affordability of medicines in Georgia” attempted to obtain reliable data on these aspects and documents tendencies of change over the course of 6 month in 2010. The survey looked at availability and price of Innovative Brands and their equivalent low price generics, analyzed collected data by type of medicine, regional differences as well as by type of pharmacy.  The survey also looks at medicine mark-ups and compares with mark-ups in European countries, measures affordability of standard treatments as percent of average subsistence monthly allowance and provides comparison of the standard treatments by innovative brands and equivalent low price generics.  Though the study has not covered all therapeutic categories, these do not detract from the importance of the above results as basis for action and as baseline for future studies.

Follow the link to obtain the full version of the report.